| Feb'20 | Nov'19 | Aug'19 | May'19 | Feb'19 | Nov'18 | Aug'18 | May'18 |
|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | |||||||
Net income (loss) | |||||||
- | - | - | 925 | - | - | - | 0 |
Adjustments to reconcile net income to net cash used in operating activities: | |||||||
Interest earned on marketable securities held in Trust Account | |||||||
1,323 | 1,426 | 1,455 | 1,128 | 729 | 0 | 0 | 0 |
Unrealized (gain) loss on marketable securities held in Trust Account | |||||||
18 | 19 | 28 | 8 | -2 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | |||||||
Prepaid expenses and other current assets | |||||||
-21 | -44 | -39 | 63 | 91 | 0 | 0 | 0 |
Accounts payable and accrued expenses | |||||||
276 | 77 | 32 | 2 | 23 | 0 | 0 | 0 |
Net cash used in operating activities | |||||||
-426 | -266 | -230 | -271 | -220 | 0 | 0 | 0 |
Cash Flows from Financing Activities: | |||||||
Advances from related party | |||||||
- | 0 | 0 | 307 | - | 0 | 0 | 0 |
Payment of offering costs | |||||||
- | 0 | 0 | 353 | 391 | 0 | 0 | 0 |
Net cash (used in) provided by financing activities | |||||||
-5,518 | 0 | 0 | 65,030 | 65,048 | 0 | 0 | 0 |
Net Change in Cash | |||||||
- | - | - | 243 | - | - | - | 0 |
Non-Cash investing and financing activities: | |||||||
Change in value of ordinary shares subject to possible redemption | |||||||
617 | 1,056 | 1,182 | 926 | 588 | 0 | 0 | 0 |
Deferred offering costs included in accrued offering costs | |||||||
- | - | - | 0 | - | - | - | 0 |